Ernexa Therapeutics Inc. (ERNA) — Institutional Holders, Q2 2026
11 institutional investment managers reported a ERNA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $236.2K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
ERNA 13F holders ranked 1–11 of 11
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | CITADEL ADVISORS#1 · 15,104 sh | 15,104 | $100.4K | 0.00% | -54.3% |
| 2 | VANGUARD FIDUCIARY#2 · 8,336 sh | 8,336 | $55.4K | 0.00% | -67.2% |
| 3 | Dauntless Investment Group#3 · 6,000 sh | 6,000 | $39.9K | 0.03% | -99.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT#4 · 5,684 sh | 5,684 | $37.8K | 0.00% | -78.6% |
| 5 | Tradewinds Capital Management#5 · 361 sh | 361 | $2.4K | — | New |
| 6 | BlackRock#6 · 33 sh | 33 | $219.00 | 0.00% | -96.0% |
| 7 | ASSETMARK#7 · 5 sh | 5 | $33.00 | — | -96.2% |
| 8 | BNP PARIBAS FINANCIAL MARKETS#8 · 1 sh | 1 | $7.00 | 0.00% | -90.0% |
| 9 | SBI Securities , Ltd.#9 · 1 sh | 1 | $7.00 | — | -83.3% |
| 10 | Steward Partners Investment Advisory#10 · 0 sh | 0 | $1.00 | 0.00% | New |
| 11 | Activest Wealth Management#11 · 0 sh | 0 | $0.00 | — | -100.0% |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.